Background {#S1}
==========

Speech is one of five heritable verbal traits (speech, language, reading, writing, spelling) in which some children have developmental delays or disorders ([@R68]; [@R80]). As with the other verbal traits, speech delays and disorders occur in both idiopathic contexts, and in the context of complex neurodevelopmental disorders (CND). The term *complex* in the latter classification is used to include environmental contributions to neurodevelopmental disorders. The goal of the present study was to estimate the prevalence of speech disorders and the prevalence of motor speech disorders in a database of audio-recorded speech samples from speakers with one of eight types of CND. The following is an overview of classification terms and concepts used in this paper.

Classification terms and concepts in childhood speech sound disorders {#S2}
---------------------------------------------------------------------

Although there is international consensus on *Speech Sound Disorders* (*SSD*) as the cover term for childhood (*paediatric* in medical contexts) speech and motor speech disorders (excluding stuttering), there is currently no consensus on standardized measures and a classification system to identify and quantify the severity of types of SSD ([@R3]; [@R5]; [@R30]; [@R50]; [@R51]; [@R88]). A comparative analysis of measures and classification systems in SSD is beyond the focus of the present report. It is useful, however, to describe four dichotomies that are addressed in classification proposals for SSD that are central to discussions of the prevalence estimates based on findings described in the present study.

Idiopathic SSD and SSD in CND {#S3}
-----------------------------

As shown in [Figure 1](#F1){ref-type="fig"}, the primary dichotomy in classification systems for childhood SSD is the division introduced -- SSD in children with no known developmental involvements and SSD in children with disorders affecting cognitive, structural, sensory, motor, and/or affective development. Issues in and alternative perspectives to this categorical rather than dimensional classification of SSD in [Figure 1](#F1){ref-type="fig"} have been described for speech pathology (e.g., [@R33]; [@R89]) and in other literatures (e.g., [@R2]). In introductory textbooks in SSD, the primary focus is on idiopathic SSD, with disorders that have SSD in the context of CND typically sampled in chapters on 'special populations' (e.g., children with hearing disorders, children with craniofacial disorders, children with autism spectrum disorders). Unlike the idiopathic SSD literature, many CND in which speakers are at increased risk for speech disorder have their own research and clinical journals, professional associations, clinical specialists, and advocacy groups. This research, educational, and clinical separation of the two contexts for SSD is a scientific constraint on research addressing common biobehavioural questions.

Speech errors and speech delay {#S4}
------------------------------

A second dichotomy shown in [Figure 1](#F1){ref-type="fig"} is the division of speakers with SSD in each context into two classifications of speech disorders. Some speakers' speech errors consist solely of common clinical distortions of speech sounds in challenging phonetic feature classes, such as in American English, distortions of the sibilant consonant in '*s*ee' (sometimes referred to as a *lisp*) or distortions of the rhotic consonant in '*r*ay.' Other speakers, in addition to distorting some speech sounds, have age-inappropriate deletions of speech sounds and/or substitutions of speech sounds for one another. Unlike speakers with only speech sound distortions, speakers with age-inappropriate speech sound deletions and/or substitutions are at risk for delays and disorders in the four other verbal traits listed previously: language, reading, writing and spelling ([@R43]). Conventional classification terms for this dichotomy, respectively, are *articulation disorder* and *phonological disorder* ([@R5]). As defined presently, the classification system in this paper uses the terms Speech Errors (SE) for articulation disorder (only distortions), and Speech Delay (SD) for phonological disorder (deletions/substitutions and optionally distortions). Point-prevalence estimates using convenience and population-based samples of adults average 1.5--2% SE ([@R14]); population-based estimates of the prevalence of SD at 4--8 years in three countries average 3.6% ([@R11]; [@R74]; [@R93]). As indicated previously, estimates of the prevalence of speech and motor speech disorders in CND are fractionated, with no research to date using the same or comparable methods, measures, and classification system with a representative sample of speakers with CND ([@R61], [@R62]).

Normalization and persistence of SE and SD {#S5}
------------------------------------------

As shown in [Figure 1](#F1){ref-type="fig"}, a third SSD classification dichotomy differentiates speech disorders that normalize with or without treatment during the speech acquisition period from those that persist beyond the well-documented stages of speech development. The classification system to be described classifies speakers with SE (i.e., only speech sound distortions) past 9 years of age at assessment as having Persistent Speech Errors (PSE) and speakers with SD (i.e., speech sound deletions and/or substitutions and optionally distortions) past 9 years of age at assessment as having Persistent Speech Delay (PSD). As shown in [Figure 1](#F1){ref-type="fig"} and used in the present research, it is useful for many purposes to aggregate speakers younger and older than 9 years at assessment within the same research group or cohort (i.e., SE/PSE and SD/PSD).

Speech disorder and motor speech disorder {#S6}
-----------------------------------------

A fourth classification dichotomy in SSD, the primary focus of the present paper, addresses the hypothesis that SD and particularly PSD in some speakers may be associated with delays in neuromotor development. Processing deficits in neurocognitive domains are widely studied in idiopathic SD and other verbal trait disorders, whereas research in processing deficits in neuromotor domains in children with idiopathic speech-language deficits is less well-developed. In addition to the possibility of Childhood Apraxia of Speech (CAS; a neuromotor deficit in speech planning/programming) or Childhood Dysarthria (CD; a neuromotor deficit in speech execution), there is continuing research on the hypothesis of a third motor speech classification characterized by a delay in the development of precise and stable articulation that does not meet criteria for dysarthria or apraxia of speech (e.g., [@R4]; [@R6]; [@R16]; [@R17]; [@R20]; [@R36]; [@R46]; [@R47]; [@R61]; [@R86]; [@R87]; [@R97]). As shown in [Figure 1](#F1){ref-type="fig"} and described presently, Speech Motor Delay (SMD) has recently been proposed as a classification term for children proposed to have this third type of developmental deficit in speech motor processes ([@R57]; [@R65]).

Neurocognitive and neuromotor processes in speech and motor speech disorders {#S7}
----------------------------------------------------------------------------

The classification entities in [Figure 2](#F2){ref-type="fig"} are part of a research framework termed the Speech Disorders Classification System (SDCS; [@R55], [@R56]; [@R65]). As shown in the top section of [Figure 2](#F2){ref-type="fig"}, distal substrates of speech and motor speech disorders include genomic, neurodevelopmental, and environmental risk and protective factors. Proximal substrates in the second section are divided into three speech processing domains -- Representation, Transcoding, and Execution -- each of which are mediated by feedforward and feedback processes. This generic sketch is based on many contemporary speech processing perspectives (e.g., [@R15]; [@R18]; [@R19]; [@R37]; [@R76]; [@R83]; [@R95]; [@R96]). The two speech disorders in the third section and reviewed previously, SD and SE, are presumed to be due to delays in auditory and somatosensory representational processes (e.g., [@R40]; [@R76]). A deficit in Transcoding, a cover term for planning and/or programming speech movements, is generally proposed as the speech processing deficit in CAS ([@R72]; [@R83]). Execution deficits, including deficits in the spatiotemporal movements in speech, prosody, and voice, are proposed to underlie CD as well as the recently proposed SMD. The term 'delay' in the latter classification is supported by findings indicating high early normalization rates in children with concurrent idiopathic SD ([@R60]). The fourth section in [Figure 2](#F2){ref-type="fig"} includes the behavioural markers currently used to identify the subtypes of SE and Motor Speech Disorder (MSD) shown above each sign or measure. The Method section and a Supplement for each of the papers in this research series include additional information on classification methods and measures.

Statement of purpose {#S8}
--------------------

Estimates of the prevalence of speech disorders and motor speech disorders in speakers with different CND are not presently available in research using the same methods, measures, and classification system. The goal of the present research was to obtain initial estimates of the prevalence of speech disorders and motor speech disorders in samples of persons with CND in a database of audio-recorded conversational speech samples from 346 speakers with one of eight types of CND. The hypothesis is that using similar methods, measures, and cross-classification system, estimates of the prevalence of motor speech disorders in persons with some types of CND will be significantly higher than recent estimates of the prevalence of motor speech disorders in children with idiopathic SD.

Method {#S9}
======

Participants {#S10}
------------

[Table 1](#T3){ref-type="table"} includes summary assessment, demographic, and cognitive-language information for participants in convenience samples of eight types of CND. Participants were recruited during the past three decades in research with investigators in several USA cities. All participants were assented and/or consented using procedures and forms approved by institutional review boards at the University of Wisconsin-Madison, the Mayo Clinic-Rochester, Minnesota, and research and clinical institutions in multiple cities where the participants were recruited and assessed. [Appendix 1](#APP1){ref-type="app"} includes the inclusionary criteria for participation in each of the eight study samples and a brief description of participants. As described presently, each of the 346 audio-recorded conversational samples that comprise the database for the present study were obtained using the same or comparable recording instrumentation, recording procedures, conversational speech sampling protocol, data reduction protocol and data reduction software. Data reduction for all speech samples from all groups was completed by the same group of research specialists.

As shown in the first four columns in [Table 1](#T3){ref-type="table"}, only findings for participants who met SDCS criteria for classification of their motor speech status were included in the present study. A later section describes criteria for classifiable samples. The group-wise percentage of classifiable participants in the eight CND samples ranged from 88.5% to 100%, averaging 95.6%. The chronological ages of participants averaged 13.3 years and the male:female ratios across groups averaged 1.8:1. Participants in the five groups with available data had average standardized scores that were significantly lower than their typically-developing same-sexed age-matched peers on measures of cognition (*M* = 70.0; *SD* = 11.0) and language (*M* = 69.4; *SD* = 10.6).

Speech and motor speech classification {#S11}
--------------------------------------

### Cross-classification {#S12}

Cross-classification of the speech and motor speech status of each participant was completed using an analytic termed the Speech Disorders Classification System Summary (SDCSS; [@R28]). [Figure 3](#F3){ref-type="fig"} includes sample SDCSS outputs from the computer software termed *Programs to Examine Phonetic and Phonologic Evaluation Records* ([@R45]).

The SDCSS cross-classifies an individual speaker's (upper panel) or a group of speakers' (lower panel) speech and motor speech status using speech, prosody, and voice data obtained from a conversational speech sample and standardization reference data from 200 typically-developing speakers ([@R44]; [@R52]). SDCSS findings provided the primary prevalence information for the present research. It is efficient first to describe the principal elements of the SDCSS, followed by description of the measures used to identify each of the speech and motor speech classifications in [Figure 3](#F3){ref-type="fig"}.

The rows in the SDCSS include the speech disorder classifications discussed previously, arranged vertically in order of increasing severity of involvement. The software classifies a speaker as having Normal (or Normalized) Speech Acquisition (NSA) if the speaker does not have in their conversational speech at assessment, any speech sound deletions, substitutions, or distortions (including additions) that are inappropriate for their age. SE, or PSE if the speaker is older than 9 years, is the classification assigned to speakers with age-inappropriate speech sound distortions. SD, or Persistent PSD if the speaker is older than 9 years, is the classification assigned to speakers with age-inappropriate speech sound deletions or substitutions. As described previously ([Figure 1](#F1){ref-type="fig"}), a slash convention is used to aggregate speakers younger and older than 9 years of age with the same class of speech disorder (i.e., SE/PSE and SD/PSD).

The columns in [Figure 3](#F3){ref-type="fig"} include five motor speech classifications arranged left to right in presumed order of increasing severity of involvement: No Motor Speech Disorder (No MSD), SMD, CD, CAS and concurrent CD & CAS. The purpose of the concurrent classification, CD & CAS, is to acknowledge the genomic, neuropathological, and clinical correlates of deficits in both neuromotor planning/programming (apraxia) and neuromotor execution (dysarthria) phases of speech production. Examples and discussion of the neurogenetic implications of concurrent apraxia and dysarthria compared to apraxia alone are increasingly emergent in the *FOXP2* and other speech-genetics literatures (e.g., [@R7]; [@R9]; [@R12]; [@R32]; [@R48]; [@R73]; [@R82]; [@R92]). The 'X' in the upper sample SDCSS in [Figure 3](#F3){ref-type="fig"} cross-classifies a speaker's speech and motor speech status -- in the present example, the 18-year-old daughter ("T") of a woman ("B") in a case study of a family with persistent CAS associated with a mutation in *FOXP2* ([@R59]). As shown, this participant is cross-classified as having PSD (speech axis) and CD & CAS (motor speech axis). In the lower sample SDCSS in [Figure 3](#F3){ref-type="fig"}, the percentages in the cells and marginal totals are group-wise findings from 28 children with CAS, classified by consensus using two different diagnostic procedures for CAS ([@R71]). As shown, concurrent CD & CAS was approximately as prevalent as CAS alone in this sample of children recruited for CAS.

### Classification conventions {#S13}

The SDCSS is a phenotype analytic in which the five classifications within speech disorders and the five classifications within motor speech disorders are each mutually exclusive. Therefore, as shown in the example of grouped SDCSS data in [Figure 3](#F3){ref-type="fig"}, the marginal values for each axis total 100%. The five mutually exclusive classifications are accomplished using two conventions.

First, in addition to identifying speakers with no speech errors, the NSA classification identifies speakers with age-appropriate deletions, substitutions, and/or distortions (speakers with such behaviours in conversational speech are coded NSA-in the PEPPER software; [@R54], Appendix). Thus, NSA classifications include speakers with no speech errors, and is also the default classification for participants whose number and/or type of speech errors do not meet criteria for SE (or PSE) or for SD (or PSD).

Second, the SDCSS software classifies speakers who meet criteria for more than one of the speech disorders or the motor speech disorders as having the more severe disorder. Thus, a speaker who meets criteria for both SE and SD (or PSE and PSD if older than 9 years) is classified as SD or PSD (i.e., the more severe of the two types of speech disorders). Similarly, for speakers who meet criteria for both SMD and any of the other three motor speech disorders classifications (CD, CAS, or CD & CAS), the program classifies the speaker as having the other presumably more severe motor speech disorder.

Measures and classification procedures {#S14}
--------------------------------------

The assessment protocols varied somewhat for each of the eight participant groups in [Table 1](#T3){ref-type="table"}, with participants in some of the groups receiving more extensive original assessments. As described, each of the eight study samples included a conversational sample using comparable interactional questions and responses to encourage participants to talk about their daily activities ([@R64]). [Appendix 2](#APP2){ref-type="app"} includes descriptions of the five speech and motor speech classifications, and for participants meeting classification criteria for CD, the five dysarthria subtypes. SDCS classifications are completed by software that provides standardized speech, prosody, and voice measurement (z-scores) using two reference databases of typical speakers 3 to 80 years of age ([@R44]; [@R52]). The speech classifications were made using a program that has been used for previous classification research in speech disorders ([@R54], Appendix Table A; [@R58], Appendix A). The motor speech classifications in the present [Appendix 2](#APP2){ref-type="app"} were developed in research to identify genomic and phenotypic substrates of childhood speech sound disorders of known and unknown origin. The perceptual and acoustic signs of dysarthria and dysarthria subtypes were based on operationalized adaptations of [@R10] diagnostic signs of neuro-genic motor speech disorders. A Supplement for this research series includes detailed information on classification methods \[[Supplementary Data](#SD1){ref-type="supplementary-material"}\]. Several reports provide information on the development and validation of the measures and normative reference data ([@R28]; [@R57]; [@R67]; [@R69]; [@R72]; [@R78]).

Data from some of the original participants had to be excluded from the present research due to missing information on one of the measures needed to classify their motor speech status. As shown in [Table 1](#T3){ref-type="table"}, the motor speech status of 4.4% of the original CND participants could not be classified (100% -- 95.6% classifiable). The primary reason motor speech status could not be classified was because the conversational speech sample did not include the minimum of 40 pause opportunities needed to compute a score on the measure used to identify CAS (termed the Pause Marker; see [Supplement](#SD1){ref-type="supplementary-material"}). In clinical practice, such children are typically resampled on the same or another day to obtain a sufficient number of pause opportunities, but such information was not available for participants in the database. The other reason some samples could not be classified was that a participant had an indeterminate Pause Marker score that could not be resolved using the Supplementary Pause Marker Index (see [Supplement](#SD1){ref-type="supplementary-material"}). Resolution of indeterminate Pause Marker scores requires information from a nonword repetition task ([@R67]) that was not yet available for research at the time some of the participants in the eight CND groups were assessed.

Data reduction and reliability estimates {#S15}
----------------------------------------

Four research specialists completed transcription, prosody-voice coding, and acoustic analyses of the conversational speech samples and transcription of the nonword repetition task. For estimates of intrajudge reliability, each specialist completed a second analysis of the samples she had originally reduced. For estimates of interjudge reliability, each specialist completed an approximately equal number of samples completed by one of the other specialists.

Estimates of the interjudge and intrajudge reliability for all data reduction tasks were based on approximately 20% samples of participants in the four CND groups with the highest prevalence of motor speech disorder (see [Figure 6](#F6){ref-type="fig"}). A total of 34 randomly selected conversational speech samples included 10 samples from participants with Down syndrome, 4 samples from participants with 22q11.2 deletion syndrome, 10 samples from participants with Idiopathic Intellectual Disability, and 10 samples from participants with fragile X syndrome.

[Table 2](#T4){ref-type="table"} is a summary of point-to-point interjudge and intrajudge agreement percentages for the three types of data reduction. The findings for the four CND groups were group-averaged (i.e., the averaged percentage of agreement findings for each of the four groups were divided by four). As shown in the reliability estimates in [Table 2](#T4){ref-type="table"}, interjudge and intrajudge percentages of agreement were similar to the approximately mid-70% to mid-90% ranges reported in reviews of reliability findings in the speech sound disorders literature ([@R31]; [@R62]; [@R66]). The average reliabilities in the mid-80% for variables assessed using transcription, prosody-voice coding, and acoustics systems within each of the four CND groups with significant motor speech disorders is viewed as particularly positive given the diverse perceptual and acoustic signs of deficits in speech, prosody, and voice assessed in the measures shown in the [Supplement](#SD1){ref-type="supplementary-material"}.

Statistical analyses {#S16}
--------------------

Statistical findings are primarily descriptive, with some inferential statistics completed to guide discussion and interpretation of findings. To minimize Type II errors in these initial prevalence comparisons, many based on relatively small cell sizes, the number of inferential statistical tests were minimized and treated family-wise (see [@R13]; [@R35]; [@R41]).

Results and discussion {#S17}
======================

[Figure 4](#F4){ref-type="fig"} includes the cross-classification findings for the prevalence of speech and motor speech disorders in the 346 participants in the eight CND groups. The summary cross-classification finding derived from the data in [Figure 4](#F4){ref-type="fig"} warrants comment before examining the individual data for each of the eight CND. As shown in the upper left data cell, 37.3% (129/346) of the participants were cross-classified as NSA and No MSD at assessment. Thus, by subtraction, a total of 62.7% (217/346) of participants in the eight CND -- over 60% of participants -- had a speech and/or a motor speech disorder at assessment. The following sections report prevalence findings and discuss implications of findings for each type of speech and motor speech classification ([Figure 2](#F2){ref-type="fig"}) for participants in each of the eight CND.

Speech disorders in eight CND {#S18}
-----------------------------

### High and low prevalence groups {#S19}

[Figure 5](#F5){ref-type="fig"} includes the prevalence findings for speech classifications within each of the CND groups. Groups are ordered vertically in the two columns by the highest to the lowest total prevalence of the two classes of speech disorders, SE and SD. Using an arbitrary 50% criterion, at least half of the participants in the first five of the eight CND (Down syndrome \[DS\], Idiopathic Intellectual Disability \[IID\], Galactosemia \[GAL\], fragile X syndrome \[FXS\], and 22q11.2 Deletion syndrome \[22q\]) were classified as either SE/PSE or SD/PSD. Fewer than 50% of the participants in the other three CND (16p11.2 \[16p\]; Severe Traumatic Brain Injury \[TBI\], and Autism Spectrum Disorder \[ASD\]) met classification criteria for either of the two speech disorders classifications. The large range in the prevalence of the two classes of speech disorders across the eight CND in [Figure 5](#F5){ref-type="fig"}, particularly for SD/PSD (16.7%−93.3%), is consistent with the heterogeneous neurocognitive and neuromotor deficits posited to underlie speech sound deletions, substitutions, and distortions, with implications for genetic and genomic correlates and clinical management.

Speech errors/persistent speech errors {#S20}
--------------------------------------

### Prevalence {#S21}

The prevalence of SE or PSE as the only speech disorder in participants in the eight groups of speakers with CND averaged 11.4%, with prevalences in [Figure 5](#F5){ref-type="fig"} ranging from 0% (22q, ASD) to 43.5% (IID). Thus, SE/PSE as the only speech disorder was relatively infrequent in the present samples of speakers with CND.

### Discussion {#S22}

The high percentage of PSE (43.5%) in the IID group (*M*: 36.4 years; *SD*: 7 years) is of interest. Unlike participants in the other CND groups, the intellectual deficit in persons in this group was idiopathic, rather than associated with syndromic and other neurodevelopmental disorders with well-described phenotypic deficits in sensorimotor domains. A research question that cannot be addressed with the current database is whether PSE in persons with IID was a residual of earlier SE or whether it was a residual of earlier SD. That is, did these speakers always have SE/PSE, or were their common and/or uncommon speech sound distortions ([@R54]; Appendix) at assessment in their third decade of life the residual of prior SD/PSD with distortions? Tracking such longitudinal speech and motor speech phenotypes in appropriately selected and controlled CND groups with different types and severity of intellectual deficits could be informative for speech-genetics research. A number of instrumental methods (e.g., palatography, ultrasound, kinematics, motion capture tracking) are becoming increasingly available for detailed phenotypic description of SE/PSE (cf. [@R25]). Such fine-grained data on SE/PSE in persons with selected CND should inform accounts of the pathobiological correlates of misarticulations, in turn leading to treatment targeting for the distortions that maximally contribute to speakers' intelligibility, comprehensibility, and acceptability (e.g., [@R29]; [@R79]; [@R94]).

Speech delay/persistent speech delay {#S23}
------------------------------------

### Prevalence {#S24}

The percentage of participants with SD/PSD in the eight CND, as shown in [Figure 5](#F5){ref-type="fig"}, ranged from 16.7% (ASD) to 93.3% (DS), averaging 40.0%.

### Discussion {#S25}

A research implication of this wide prevalence range for SD/PSD across CND is the potential for comparative study of speech processing deficits in SD ([Figure 2](#F2){ref-type="fig"}). As reviewed previously, early and persistent SD is posited to reflect deficits in representational processes, rather than in speech production deficits in transcoding (planning/programming) or in speech execution. Research that compares the deletion and substitution errors of SD/PSD in different CND to those in children with idiopathic SD could inform questions about the single and multiple neural and psycholinguistic loci of speech processing deficits in SD ([@R39]).

The present cross-classification findings for SD/PSD in CND underscore an important clinical question. Findings in [Figure 4](#F4){ref-type="fig"} indicate that whereas 27.6% (35/127) of the participants with SD/PSD had No MSD, the remaining 72.4% (92/127) also had one of the four types of motor speech disorders discussed in the next section. A two-group test of proportions indicated that the latter group was significantly more prevalent in the present database (Fisher's exact test; *p*-value = 0.000). For the transcoding deficits in CAS and the execution delays/deficits in SMD and CD ([Figure 2](#F2){ref-type="fig"}), respectively, current trends are to base speech treatment wholly or substantially on principles of motor learning (e.g., [@R26]; [@R27]). If speech sound deletions and substitutions in persons with idiopathic SD or PSD are proposed to reflect cognitive rather than motor speech neurodevelopmental constraints ([Figure 2](#F2){ref-type="fig"}), a clinical question is whether treatment based wholly or substantially on the principles of motor-learning is appropriate for the nearly 3/4ths (72.4%) of the present speakers with CND, SD/PSD, and concurrent motor speech disorder (i.e., SMD, CD, CAS, or CD & CAS). Rather, treatment would seem to be more appropriately based on each individual speaker's cross-classification findings, which include the type and severity of involvement in both cognitive and motor domains ([@R38]; [@R68]).

Motor speech disorders in eight CND {#S26}
-----------------------------------

### High and low prevalence groups {#S27}

[Figure 6](#F6){ref-type="fig"} includes findings for the prevalence of the five classifications of MSD (including No MSD) in the eight samples of participants with CND. Although not in the same order, the five CND with the highest prevalence of SD in [Figure 5](#F5){ref-type="fig"} (DS, IID, GAL, FXS, 22q) also had the highest prevalence of one of the four types of MSD in [Figure 6](#F6){ref-type="fig"} (DS, 22q, IID, FXS, GAL). The following sections review prevalence findings for each of the four MSD.

Speech motor delay {#S28}
------------------

### Prevalence {#S29}

As shown in [Figure 4](#F4){ref-type="fig"}, 25.1% of the participants in the eight groups of participants with CND met SDCS requirements for SMD. The prevalence of SMD in the adults with IID (47.8%; [Figure 6](#F6){ref-type="fig"}) was nearly double the group-averaged mean of the prevalence of SMD in the other seven groups (23.5%), which ranged from 14.3% to 29.4%. In comparison, the per-participant prevalence of SMD in a sample of 415, 3-to 16-year-old participants with idiopathic SD from six cities in the U.S. was 12% ([@R65]).

### Discussion {#S30}

The present high prevalence of SMD in participants with CND, together with the previous prevalence findings for SMD in children with SD ([@R65]), supports SMD as a classification entity for speakers with imprecise and/or unstable speech, prosody, and/or voice that does not meet criteria for CD and/or CAS. In the present data, of the 61 participants who did meet criteria for CD and/or CAS, 52 (85.2%) also met criteria for SMD. As expected, because both SMD and CD are disorders of speech execution ([Figure 2](#F2){ref-type="fig"}), 89.1% of the participants with CD also met criteria for SMD, whereas 73.3% of the participants with CAS also met criteria for SMD; a Fisher's exact test was non-significant (*p*-value = 0.204).

In addition to the high prevalence of SMD in seven of the CND groups (total group average = 23.5%), the substantial prevalence of SMD in participants with IID (47.8%) discussed previously is of particular research and clinical interest. As described previously, nearly 80% of the adult participants with IID met criteria for either NSA (34.8%) or SE/PSE (43.5%), the latter of which was the highest percentage obtained among the eight groups of CND. Only approximately 20% of these participants had the persistent speech sound deletions or substitutions that define PSD. As described in the original study of these participants ([@R75]) and in item level-detail on their performance on the Precision-Stability Index ([@R69]), their most prevalent perceptual and acoustic signs of SMD were in the domains of prosody and voice (i.e., not in the domain of speech production). Thus, SMD may be an especially appropriate phenotypic classification for speakers with intellectual disability whose speech perceptually suggests a motor component that does not meet criteria for the processing deficits in transcoding that define CAS or the processing deficits in execution that define CD ([Figure 2](#F2){ref-type="fig"}).

Last, SMD may have an important role in epidemiological and other studies of the prevalence and phenotype of motor speech disorders in CND. Subsequent discussion speculates on the possibility first proposed in preliminary research in SMD ([@R57]) that SMD is the true-positive classification for the false-positive classifications of CAS in research and clinical speech pathology ([@R1]; [@R49]).

Childhood dysarthria {#S31}
--------------------

### Prevalence {#S32}

The prevalence of CD in the eight samples of CND, as shown in [Figure 4](#F4){ref-type="fig"}, was 13.3%, with an additional 4.9% of participants meeting criteria for concurrent CAS (CD & CAS) at assessment. Thus, a total of 18.2% of the present participants met criteria for either CD alone or concurrent with CAS, in comparison to the total percentage of participants with SMD (25.1%). The percentages of participants with CD or CD & CAS in the first five CND in [Figure 6](#F6){ref-type="fig"}, (DS \[60%\], 22q \[41.2%\], IID \[17.4%\], FXS \[32.1%\], and GAL \[29%\]) were considerably higher than the percentages in the remaining three CND. Notably for neurogenetic research questions, the prevalence of CD alone was the same or higher than the prevalence of CD & CAS in each of the eight CND. In comparison to the above values, 3.4% of 415 children with idiopathic SD ([@R65]) met criteria for CD and none met criteria for concurrent CD & CAS.

### Subtypes of childhood dysarthria {#S33}

[Table 3](#T5){ref-type="table"} includes prevalence estimates for the five subtypes of dysarthria listed in the last five rows of [Appendix 2](#APP2){ref-type="app"}. The dysarthria subtype indices are each comprised of 12--19 of the 34 signs in the Dysarthria Index. As shown in the [Supplement](#SD1){ref-type="supplementary-material"}, the SDCS signs of subtypes of dysarthria were operationalized and standardized using the Mayo Clinic classification system definitions and subscale item weightings ([@R10]). Subtype signs are not mutually exclusive, with some signs proposed to be diagnostic of more than 1 of the 5 subtypes of dysarthria ([@R10]). Details on how the percentile values in [Table 3](#T5){ref-type="table"} were derived from a database of 442 participants at risk for childhood motor speech disorders are described in a technical report ([@R28]; pp. 203--204). Values ≤ 10^th^ percentile on each dysarthria subtype index were classified as positive for that subtype.

As shown in [Table 3](#T5){ref-type="table"}, the subtypes for which at least 50% of the participants in each of the eight CND were positive are bolded. For example, in the first data row in [Table 3](#T5){ref-type="table"}, 77.8% of the participants with DS who met criteria for CD alone or CD & CAS were positive for Ataxia. As is consistent with the childhood and adult literatures in developmental and acquired dysarthria, participants may be positive for one subtype of dysarthria (*pure*) or more than one subtype (*mixed*). Mixed dysarthrias may be in part due to the high collinearity among subtypes with some of the same clinical signs (e.g., slow rate is common to several subtypes of dysarthria).

With the exception of the findings for DS discussed next, the estimates in [Table 3](#T5){ref-type="table"} are preliminary, due to the low number of participants with CD (63) that comprise the denominators for the percentage estimates across the 120 cells in [Table 3](#T5){ref-type="table"} (i.e., 8 CND x 5 dysarthria subtypes x 3 classifications of CD \[CD, CD & CAS, total\]). Specifically, other than the total of 27 participants with DS ([Table 3](#T5){ref-type="table"}, fourth data column), the percentage of participants in each CND that met percentile criteria for dysarthria subtypes are based on from 2 to 9 participants with CD. Therefore, with the exception of the following discussion of findings for participants with DS, the dysarthria subtype findings for the remaining CND in [Table 3](#T5){ref-type="table"} are provided only for their possible value to generate additional questions for CND-speech research in dysarthria.

Findings for participants with DS in [Table 3](#T5){ref-type="table"} for the 60% (27/45) who met criteria for CD or CD & CAS are interpreted as strong support for Ataxia as the prevalent subtype of their CD. Ataxic dysarthria was prevalent in participants with DS with both CD alone (82%) and CD & CAS (70%). As shown in [Table 3](#T5){ref-type="table"}, the only other CD subtype meeting the 50% criteria for these participants was Hyperkinetic, which met the criteria of 50% of signs ≤ 10^th^ percentile for 5 of the 10 participants with CD & CAS. As indicated in [Table 3](#T5){ref-type="table"}, ataxic dysarthria is associated with deficits in cerebellar processes (e.g., [@R22]; [@R34]), with implications for genomic and speech treatment research for persons with DS (cf. [@R90], [@R91]).

Childhood apraxia of speech {#S34}
---------------------------

### Prevalence {#S35}

The previous findings ([Figure 4](#F4){ref-type="fig"}) indicated that CD alone occurred somewhat more frequently (13.3%) than CAS alone (4.3%). As shown in [Figure 6](#F6){ref-type="fig"}, CD was more prevalent than CAS in 6 of the eight CND, with the prevalence of participants with CAS alone ranging from 0% (ASD) to 11.8% (22q). In comparison to these values, 2.4% of 415 children with idiopathic SD ([@R65]) met criteria for CAS and none met criteria for concurrent CD & CAS.

### Discussion {#S36}

The prevalence finding of 4.3% for CAS in CND (and an additional 4.9% CAS concurrent with CD \[[Figure 4](#F4){ref-type="fig"}\] to be discussed), supports the efficiency of studying CAS in the context of CND. A recent population-based, point-prevalence estimate of CAS in children with idiopathic SD is 1 per 1,000 children at 4 to 8 years of age ([@R65]). The diverse and well-studied neurogenomic substrates of many CND provide additional rationale for studying CAS in CND that have high rates of motor speech disorders ([@R56]).

The present prevalence findings for CAS in the context of CND also have implications for continuing research and clinical findings indicating that CAS is overdiagnosed ([@R70]). As noted previously, reviews of clinical studies in several countries indicate false positive CAS rates ranging from approximately 50% to approximately 90% ([@R1]; [@R49]), with SMD possibly accounting for a substantial percentage of the false positives ([@R57]). Item analyses of the speech, prosody, and voice signs most associated with false positives for CAS need to be completed to test the validity of this speculation ([@R60]).

A second question raised by the prevalence findings for CAS in the context of CND is the low prevalence of CAS in three of the eight CND compared to the other five CND ([Figure 6](#F6){ref-type="fig"}). Because the measurement and classification procedures were similar for all groups, the implication is that participants in the latter groups do not have the neurogenetic substrates of CAS present in participants in the first five groups. Reviews of the neurogenetic literatures in each of the eight CND are beyond the scope of the present prevalence study, but associated questions could possibly be resolved by results from meta-analyses of genetic, genomic, neurologic, and behavioural findings in the respective literatures.

Childhood dysarthria & childhood apraxia of speech {#S37}
--------------------------------------------------

### Prevalence {#S38}

The prevalence of concurrent CD & CAS (4.9%), as shown in [Figure 4](#F4){ref-type="fig"}, was marginally higher than the prevalence of CAS alone (4.3%) within the 9.2% of the present speakers with CND meeting criteria for CAS. As indicated for the five CND with the highest prevalence of motor speech disorders in [Figure 6](#F6){ref-type="fig"}, the percentage of participants with CD & CAS was higher than CAS alone in two CND groups (DS, GAL), the same as CAS alone in one group (22q) and lower than CAS alone in two groups (IID, FXS).

### Discussion {#S39}

The present findings for the prevalence of CD & CAS compared to CAS alone in CND support trends in the genetic and other literatures in CAS. Although the earliest phenotype of the British family with a disruption in *FOXP2* described a disorder consistent with CAS ([@R84]), later descriptions of the family and increasingly other studies of CAS associated with *FOXP2* and other genes have broadened the phenotype to include CD (e.g., [@R24]; [@R23]; [@R33]; [@R42]; [@R48]; [@R59]; [@R63]; [@R81]; [@R85]).

Conclusion {#S40}
==========

Methodological considerations {#S41}
-----------------------------

Three methodological considerations warrant comment. First, the three behavioural measures of SMD, CD, and CAS used in this research have only recently become available. Each measure warrants additional research by other research groups using additional and alternative measurement modalities (e.g., neurologic, physiologic, kinematic) to cross-validate the diagnostic classifications and provide more finely-grained phenotypic detail. Second, generalizations from the present findings are limited to participants with the eight types of CND that were available in an audio-recorded database of conversational speech samples. Moreover, generalizations are limited to persons with the cognitive, linguistic, and affective abilities and dispositions to complete a continuous speech task and other SDCS supplementary tasks. Future estimates of the prevalence of speech and motor speech disorders in CND should include CND selected specifically for their genomic, neurodevelopmental, and behavioural similarities and differences. Last, the descriptive and inferential statistical findings from the present participants and methods were limited by the available cell sizes within each CND group, and consequently, within each of the four types of motor speech disorders.

Conclusion {#S42}
----------

Pending cross-validation, the primary findings of this research support the hypothesis that speech disorders, and notably motor speech disorders are substantially prevalent in persons with some types of complex neurodevelopmental disorders. A corollary conclusion is that comparative study of motor speech disorders in the context of complex neurodevelopmental disorders has the potential to inform programmatic research in biobehavioural causal pathways, treatment efficacy, and in primary, secondary, and tertiary forms of prevention.
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======================

We thank each of the following colleagues for her or his contribution to this research: Leonard Abbeduto, Nancy Alarcon, Adriane Baylis, Raphael Bernier, Lois Black, Richard Boada, Roger Brown, Stephen Camarata, Thomas Campbell, Joseph Duffy, Marios Fourakis, Lisa Freebairn, Jordan Green, Sheryl Hall, Katherina Hauner, Heather Karlsson, Joan Kwiatkowski, Barbara Lewis, Jane McSweeny, Jennifer McGlothlin, Christopher Moore, Rhea Paul, Bruce Pennington, Nancy Potter, Heather Rusiewicz, Carmen Rasmussen, Alison Scheer-Cohen, Kristie Spencer, Christie Tilkens, Jan van Santen, Jennell Vick, Emily White, Carol Widder, David Wilson, and Erin Wilson.

Funding

This work was supported by grants from the National Institute on Deafness and Other Communication Disorders \[DC000496\] and a core grant to the Waisman Center from the National Institute of Child Health and Human Development \[U54 HD090256\].

Disclosure Statement

The authors report no declarations of interest.

Description and inclusionary criteria for participants in each of the eight Complex Neurodevelopmental Disorders groups (see text, [Table 1](#T3){ref-type="table"}). A technical report ([@R69]) includes speech, prosody, and voice assessment data for participants in each of the eight groups.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Eight Complex Neurodevelopmental Disorders   Abbreviation in Text   *n* Available Data   *n* Eligible for Classification   Brief Description of Participants                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Sources of the Speech Samples
  -------------------------------------------- ---------------------- -------------------- --------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------
  16p11.2 Deletion and Duplication Syndrome    16p                    111                  108                               Audio recordings of the Autism Diagnostic Observations Schedule (ADOS; [@R110]) administrations from children and adults with 16p11.2 variants obtained from the Simons -- Variation in Individuals Project ([@R117]) were collected and analyzed. Participation in the Simons VIP requires the canonical deletion or duplication (\~600 kb, chr16: 29,557,497--30,107,356; hg18), or a smaller CNV at the locus. Exclusion criteria include any other pathogenic CNVs or other neurogenetic or neurological diagnoses unrelated to 16p11.2 (e.g., tuberous sclerosis). Participant ages ranged from 3;2 to 62;0 (yrs;mos), with approximately equal numbers of males (56) and females (55). The overall percentage of 16p11.2 variants included 54.1% deletions and 45.9% duplications. A total of 23 of the 111 (20.7%) participants with 16p11.2 deletions and duplications met criteria for verbal participants with Autism Spectrum Disorder.                                                                      [@R116]. [@R117].

  22q11.2 Deletion Syndrome                    22q                    18                   17                                Inclusionary criteria included: (a) diagnosis of 22q11.2 deletion syndrome by Fluorescence In Situ Hybridization (FISH) testing or microarray, (b) 6--18 years of age, (c) English as the participant's primary language, and (d) no history of permanent bilateral hearing loss.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       [@R100]

  Autism Spectrum Disorder                     ASD                    42                   42                                Inclusionary criteria included: (a) a previous diagnosis of autism, PDD-NOS, ASD, or Asperger syndrome from a qualified clinician; (b) full scale IQ ≥ 70; (c) mean length of utterance of at least 3.0, based on transcription of a 3--5 min conversational sample; (d) \> 70% of words intelligible in the language sample; and (e) normal hearing and vision (or corrected with glasses) on standard screening. Exclusionary criteria included known craniofacial or neurological impairment or bilingual background.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                [@R113]

  Down syndrome                                DS                     50                   45                                Three samples of participants: (1) 29 participants, 10--18 years of age with a confirmed diagnosis of Trisomy 21 and no diagnosis of autism spectrum disorders; (2) 17 participants, 8--18 years of age, with a confirmed diagnosis of Trisomy 21 and no diagnosis of autism spectrum disorders; (3) 4 male participants, ages 13--20 years, with a confirmed diagnosis of Trisomy 21.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  [@R90]; [@R91]); [@R101];\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     [@R107]

  fragile X syndrome                           FXS                    30                   28                                Males ranging in age from 11--22 yrs.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  [@R98];\
                                                                                                                             Inclusionary criteria: (a) DNA or cytogenetic confirmation of the syndrome; (b) speech as the primary means of communication; (c) no more than a mild hearing loss per Chapman, Schwartz, and Kay-Raining Bird (1991) criterion; (d) ability to complete all tests; (e) nonverbal IQs \<70; (f) passed screening and follow-up psychologist assessment for ASD.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         [@R99]; [@R109]

  Galactosemia                                 GAL                    31                   31                                Inclusionary criteria: (a) a diagnosis of classic (full expression) galactosemia; (b) prior or persistent Speech Delay, as documented by a history of treatment for Speech Delay; (c) 4--17 years of age; (d) residence in the United States; (e) English as the only or first language; and (f) no history of significant hearing loss or craniofacial disorder affecting speech.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      [@R114]

  Idiopathic Intellectual Disability           IID                    26                   23                                Audiotape speech samples from adults with IID living in the Madison, WI, area. Participants were non-institutionalized, and worked at settings ranging from work activity centers to independent jobs in the community. As reported in [@R75], audiotape samples from a parent study ([@R111]) were assessed for use and tapes were removed that (a) had unacceptable signal quality or excessive background noise; (b) were from persons who were nonambulatory; (c) were from persons who sounded frankly dysarthric (six tapes), using screening criteria in [@R106]; (d) were from persons for whom records were not available on age, gender, race, or level of mental retardation; (e) were from persons outside the ages of 20 to 50 years (excepting one 53-year-old); and/or (f) were from persons outside the range of mild to moderate levels of retardation, that is, excluding borderline and severe or profound involvement as determined by AAMD classification ([@R108]) available in agency records.   [@R75]

  Severe Traumatic Brain Injury                TBI                    54                   52                                Subsample of 56 children who sustained severe pediatric traumatic brain injury (TBI) between age 1 month and 11 years. Inclusionary criteria: (a) severe TBI, defined as a Glasgow Coma Scale score ≤ 8 and a positive CT scan; (b) age at injury \< 11 years; (c) injury not known or suspected to have resulted from abuse; and (d) monolingual English home environment and no previously diagnosed neurodevelopmental, speech, or language deficits according to parent report.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     [@R102];\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     [@R103]; [@R104]

                                               Total:                 362                  346                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The five Speech classifications and five Motor Speech classifications in the SDCS are each mutually exclusive. The five dysarthria subtype classifications are not mutually exclusive. That is, a speaker can meet percentile criteria for more than one of the five listed dysarthria subtype classifications (i.e., mixed dysarthria). See [Supplement](#SD1){ref-type="supplementary-material"} for the procedures and measures used to classify each motor speech disorder.

  SDCS Classifications and Dysarthria Subtypes          Abbreviation   Age (yrs;mos) at Assessment   Description                                                                                      References^[a](#TFN2){ref-type="table-fn"}^
  ----------------------------------------------------- -------------- ----------------------------- ------------------------------------------------------------------------------------------------ ---------------------------------------------
  Five Speech Classifications                                                                                                                                                                         
   Normal(ized) Speech Acquisition                      NSA            3--80                         Does not meet criteria for any of the four Speech Disorder classifications                       2, 3, 4
   Speech Errors                                        SE             6--8;11                       Age-inappropriate speech sound distortions                                                       3, 4
   Persistent Speech Errors                             PSE            9--80                         Age-inappropriate speech sound distortions that persist past 9 years of age                      4, 5
   Speech Delay                                         SD             3--8;11                       Age-inappropriate speech sound deletions and/or substitutions                                    3, 4
   Persistent Speech Delay                              PSD            9--80                         Age-inappropriate speech sound deletions and/or substitutions that persist past 9 years of age   3, 4, 5
  Five Motor Speech Classifications                                                                                                                                                                   
   No Motor Speech Disorder                             No MSD         3--80                         Does not meet criteria for any of the four Motor Speech Disorders classifications                2, 6, 8
   Speech Motor Delay                                   SMD            3--80                         Meets PSI criterion for SMD                                                                      2, 6, 8
   Childhood Dysarthria                                 CD             3--80                         Meets DI and DSI criteria for CD                                                                 2, 6, 8
   Childhood Apraxia of Speech                          CAS            3--80                         Meets PM criterion for CAS                                                                       6, 7, 8
   Childhood Dysarthria & Childhood Apraxia of Speech   CD & CAS       3--80                         Meets SDCS criteria for CD & CAS                                                                 2, 6, 8
  Five Dysarthria Subtypes                                                                                                                                                                            
   Ataxic                                                              3--80                         Cerebellar disorder                                                                              1, 2
   Spastic                                                             3--80                         Upper motor neuron disorder                                                                      1, 2
   Hyperkinetic                                                        3--80                         Basal ganglia disorder; increased movement                                                       1, 2
   Hypokinetic                                                         3--80                         Basal ganglia disorder; decreased movement                                                       1, 2
   Flaccid                                                             3--80                         Lower motor neuron disorder                                                                      1, 2

*Notes*: PSI = Precision-Stability Index; DI = Dysarthria Index; DSI = Dysarthria Subtype Index; PM = Pause Marker.

1\. [@R10]; 2. [@R28]; 3. [@R54]; 4. [@R58]; 5. [@R61]; 6. [@R69]; 7. Shriberg et al. (2017a); 8. [@R78].

16p

:   16p11.2 deletion and duplication syndrome

22q

:   22q11.2 deletion syndrome

ASD

:   Autism Spectrum Disorder

CAS

:   Childhood Apraxia of Speech

CD

:   Childhood Dysarthria

CND

:   Complex Neurodevelopmental Disorder

DS

:   Down syndrome

FXS

:   Fragile X syndrome

GAL

:   Galactosemia

IID

:   Idiopathic Intellectual Disability

MSD

:   Motor Speech Disorder

No MSD

:   No Motor Speech Disorder

NSA

:   Normal(ized) Speech Acquisition

PEPPER

:   Programs to Examine Phonetic and Phonologic Evaluation Records

PSD

:   Persistent Speech Delay

PSE

:   Persistent Speech Errors

SD

:   Speech Delay

SDCS

:   Speech Disorders Classification System

SDCSS

:   Speech Disorders Classification System Summary

SE

:   Speech Errors

SMD

:   Speech Motor Delay

SSD

:   Speech Sound Disorders

TBI

:   Traumatic Brain Injury

![Four classification dichotomies in Speech Sound Disorders (SSD).](nihms-1524504-f0001){#F1}

![The Speech Disorders Classification System (SDCS).](nihms-1524504-f0002){#F2}

![Sample outputs from the Speech Disorders Classification System Summary (SDCSS).](nihms-1524504-f0003){#F3}

![Speech Disorders Classification System Summary (SDCSS) findings for participants in eight Complex Neurodevelopmental Disorders.](nihms-1524504-f0004){#F4}

![Percentage of participants in eight Complex Neurodevelopmental Disorders classified into one of three speech classifications.](nihms-1524504-f0005){#F5}

![Percentage of participants in eight Complex Neurodevelopmental Disorders classified into one of five motor speech classifications.](nihms-1524504-f0006){#F6}

###### 

Information for participants with one of eight types of Complex Neurodevelopmental Disorders (ordered alphabetically).^[a](#TFN3){ref-type="table-fn"}^

  Group                                       Abbreviation   Assessment   Demographic   Cognitive-Language                                                                                                                                        
  ------------------------------------------- -------------- ------------ ------------- -------------------- ------ ------ ------ ------ ---------------------------------- ---------------------------------- ---------------------------------- ----------------------------------
  16p11.2 deletion and duplication syndrome   16p            111          108           97.3                 14.7   12.4   50.9   49.1   [\*](#TFN8){ref-type="table-fn"}   [\*](#TFN8){ref-type="table-fn"}   [\*](#TFN9){ref-type="table-fn"}   [\*](#TFN9){ref-type="table-fn"}
  22q11.2 deletion syndrome                   22q            18           17            94.4                 10.2   3.3    35.3   64.7   77.8                               11.5                               77.4                               11.8
  Autism Spectrum Disorder                    ASD            42           42            100                  6      1.2    21.4   78.6   104.3                              15.7                               98.9                               17.3
  Down syndrome                               DS             50           45            90                   14.2   2.3    44.4   55.6   42.8                               6.4                                42.6                               4.4
  Fragile X syndrome                          FXS            30           28            93.3                 16     3.2    0      100    38.3                               5.4                                48.6                               4.1
  Galactosemia                                GAL            31           31            100                  8.8    2.9    35.5   64.5   86.7                               16.4                               79.6                               15.3
  Idiopathic Intellectual Disability          IID            26           23            88.5                 36.4   7      52.2   47.8   [\*](#TFN8){ref-type="table-fn"}   [\*](#TFN8){ref-type="table-fn"}   [\*](#TFN9){ref-type="table-fn"}   [\*](#TFN9){ref-type="table-fn"}
  Severe Traumatic Brain Injury               TBI            54           52            96.3                 7.3    2.9    42.3   57.7   [\*](#TFN8){ref-type="table-fn"}   [\*](#TFN8){ref-type="table-fn"}   [\*](#TFN9){ref-type="table-fn"}   [\*](#TFN9){ref-type="table-fn"}
  Totals                                                     362          346           95.6                 13.3   10.3   39     61     70                                 11                                 69.4                               10.6

Cell values for demographic and cognitive-language variables are for the 346 participants that were eligible to be classified using Speech Disorders Classification System (SDCS) measures. Standardized cognitive and language data were not currently available for participants in three of the eight groups.

Standard scores for IQ Composite: ([@R21]). IQ Scores: ([@R77]).

= no data.

Standard scores for Oral Composite: ([@R8]). Standard scores for Core Language: ([@R53]).

= no data.

###### 

Reliability estimates for phonetic transcription, prosody-voice coding, and acoustic analyses.

  Data                     Agreement Types   No. of Tokens Analyzed   Variable          Percentage of Agreement          
  ------------------------ ----------------- ------------------------ ----------------- -------------------------------- ------
  Phonetic Transcription   X                                                            Consonants                       
                                                                      2535 utterances   Broad                            93.3
                                                                      7239 words        Narrow                           77.2
                                                                                        Vowels                           
                                                                                        Broad                            85.5
                                                                                        Narrow                           75
                                             X                                          Consonants                       
                                                                      2535 utterances   Broad                            95.6
                                                                      7287 words        Narrow                           84.8
                                                                                        Vowels                           
                                                                                        Broad                            89.8
                                                                                        Narrow                           81.5
  Prosody-Voice Coding     X                                          801 utterances    Appropriate-Inappropriate        87.3
                                             X                                          Appropriate-Inappropriate        91.3
  Acoustic Analyses        X                                                            Phoneme                          
                                                                                        Duration                         
                                                                      651               Consonants                       81.9
                                                                      2754              Vowels                           81.9
                                             X                                          Phoneme                          
                                                                                        Duration                         
                                                                      710               Consonants                       84.1
                                                                      2760              Vowels                           84.7
                           X                                                            Vowel Frequency                  
                                                                      2616              F0                               97.4
                                                                      450               F1                               90
                                                                      442               F2                               90.3
                                             X                                          Vowel Frequency                  
                                                                      2632              F0                               97.5
                                                                      470               F1                               90.1
                                                                      460               F2                               94.8
                           X                                                            Pause Variables                  
                                                                      558               Pause --                         88.1
                                                                                        Non-Pause                        
                                                                      487               Appropriate -- Not Appropriate   71.9
                                                                      60                Type 1 -- Type 2                 82.7
                                             X                                          Pause Variability                
                                                                      558               Pause -- Non-Pause               86.2
                                                                      475               Appropriate -- Not Appropriate   69.7
                                                                      59                Type 1 -- Type 2                 81.8

###### 

Percentage of participants with Childhood Dysarthria (CD) and Childhood Dysarthria & Childhood Apraxia of Speech (CD & CAS) with scores ≤ 10th percentile on subtypes of CD.^[a](#TFN6){ref-type="table-fn"}^

  Complex Neurodevelopmental Disorder   Percentage of Participants with CD Subtype Score ≤ 10^th^ Percentile                                                                                                                                                                              
  ------------------------------------- ---------------------------------------------------------------------- ---- ---- ---- ---------- ----------- ---------- ---------- ----------- ---------- ---------- ----------- ---------- ----------- ------ ----------- ----------- ---------- -----------
  DS                                    45                                                                     17   10   27   **82.4**   **70.0**    **77.8**   29.4       30.0        29.6       41.2       **50.0**    44.4       17.6        30.0   22.2        29.4        20.0       25.9
  GAL                                   31                                                                     5    4    9    20.0       25.0        22.2       40.0       **50.0**    44.4       **60.0**   **50.0**    **55.6**   20.0        25.0   22.2        0.0         **75.0**   33.3
  FXS                                   28                                                                     9    0    9    **55.6**   0.0         **55.6**   44.4       0.0         44.4       22.2       0.0         22.2       **66.7**    0.0    **66.7**    44.4        0.0        44.4
  22q                                   17                                                                     5    2    7    20.0       **50.0**    28.6       20.0       **50.0**    28.6       **60.0**   **50.0**    **57.1**   **60.0**    0.0    42.9        **60.0**    **50.0**   **57.1**
  Severe TBI                            52                                                                     4    1    5    25.0       **100.0**   40.0       **50.0**   **100.0**   **60.0**   25.0       **100.0**   40.0       25.0        0.0    20.0        **75.0**    0.0        **60.0**
  IID                                   23                                                                     4    0    4    0.0        0.0         0.0        0.0        0.0         0.0        0.0        0.0         0.0        **100.0**   0.0    **100.0**   **50.0**    0.0        **50.0**
  16p                                   108                                                                    2    0    2    0.0        0.0         0.0        0.0        0.0         0.0        0.0        0.0         0.0        **50.0**    0.0    **50.0**    **100.0**   0.0        **100.0**
  Total                                 304                                                                    46   17   63                                                                                                                                                               
  Group-Averaged %                                                                                                            29.0       35.0        32.0       26.3       32.9        29.6       29.8       35.7        31.3       48.5        7.9    46.3        51.3        20.7       53.0

Bolded cells are those in which at least half (50%) of the participants with CD or CD & CAS had subscale scores ≤ 10^th^ percentile.

DS = Down syndrome; GAL = Galactosemia; FXS = fragile X syndrome; 22q = 22q11.2 deletion syndrome; Severe TBI = Severe Traumatic Brain Injury; IID = Idiopathic Intellectual Disorder; 16p = 16p11.2 deletion and duplication syndrome. None of the 42 participants with Autism Spectrum Disorder were classified as CD or CD & CAS.
